Love and stress.

Stefano G, Esch T.

Editorial 2005; 26(3): 173-174 PubMed PMID: 15990718 Keywords: Humans, Love, Neurosecretory Systems:physiology, Stress, Psychological:physiopathology,.

Full text PDF

Qualitative analysis of selected literature sources addressing the issue of homelessness.

Gabrielová J, Velemínský M.

Editorial

2015; 36(Suppl 2): 54-61

PubMed PMID: 26748528

Citation

Citation

Gabrielová J, Velemínský M. Qualitative analysis of selected literature sources addressing the issue of homelessness. Neuro Endocrinol Lett. 2015 Jan; 36(Suppl 2): 54-61

Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.

Sos P, Klirova M, Novak T, Kohutova B, Horacek J, Palenicek T.

Editorial

2013; 34(4): 287-293

PubMed PMID: 23803871

Citation

Citation

Sos P, Klirova M, Novak T, Kohutova B, Horacek J, Palenicek T. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression. Neuro Endocrinol Lett. 2013 Jan; 34(4): 287-293

Expression of heart oxytocin receptor and its mRNA in two rat strains with different activity of HPA axis.

Klenerova V, Chottova-Dvorakova M, Skopek P, Sida P, Mistrova E, Slavikova J, Hynie S.

Editorial

2011; 32(6): 805-810

PubMed PMID: 22286791

Citation

Citation

Klenerova V, Chottova-Dvorakova M, Skopek P, Sida P, Mistrova E, Slavikova J, Hynie S. Expression of heart oxytocin receptor and its mRNA in two rat strains with different activity of HPA axis. Neuro Endocrinol Lett. 2011 Jan; 32(6): 805-810

Corticotropin-releasing factor (CRF) over-expression down-regulates hippocampal dopamine receptor protein expression and CREB activation in mice.

Kasahara M, Groenink L, Olivier B, Sarnyai Z.

Editorial

2011; 32(2): 193-198

PubMed PMID: 21552199

Citation

Citation

Kasahara M, Groenink L, Olivier B, Sarnyai Z. Corticotropin-releasing factor (CRF) over-expression down-regulates hippocampal dopamine receptor protein expression and CREB activation in mice. Neuro Endocrinol Lett. 2011 Jan; 32(2): 193-198

Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro.

Kolarik M, Indra R, Adam V, Heger Z, Kopeckova K, Arlt V, Stiborova M.

Editorial

2019; 39(7): 515-524

PubMed PMID: 30860683

Citation

Citation

Kolarik M, Indra R, Adam V, Heger Z, Kopeckova K, Arlt V, Stiborova M. Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro. Neuro Endocrinol Lett. 2019 Feb; 39(7): 515-524